Gene Therapy Market Size
The Gene Therapy Market size is a key indicator of its economic value and growth potential. The global market, valued at an estimated USD 11.07 billion in 2025, is projected to reach a substantial USD 55.43 billion by 2034, with a compound annual growth rate (CAGR) of 19.60%. This significant market size is a testament to the high demand for gene therapies in a wide range of applications, including the treatment of rare genetic disorders, oncology, and neurological conditions. The market size is heavily influenced by the high cost of gene therapies, which, while expensive, often offer a one-time curative treatment, leading to long-term healthcare savings and a high value proposition.
The market size is not uniform across all segments. For instance, the oncology segment accounts for the largest portion of the market size, reflecting the high prevalence of cancer and the significant investment in this therapeutic area. Geographically, North America holds the largest portion of the market size, but the Asia-Pacific region is rapidly gaining ground. The growing market size indicates a dynamic and expanding industry with substantial opportunities for investment and innovation. The continued expansion of gene therapy applications and the development of more cost-effective manufacturing processes are expected to further drive the market size in the coming years.